These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cardiovascular benefit in the limelight: shifting type 2 diabetes treatment paradigm towards early combination therapy in patients with overt cardiovascular disease. Shehadeh N; Raz I; Nakhleh A Cardiovasc Diabetol; 2018 Aug; 17(1):117. PubMed ID: 30134893 [No Abstract] [Full Text] [Related]
6. Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy. van Stee MF; de Graaf AA; Groen AK Cardiovasc Diabetol; 2018 Jun; 17(1):94. PubMed ID: 29960584 [TBL] [Abstract][Full Text] [Related]
12. Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus. Li T; Providencia R; Mu N; Yin Y; Chen M; Wang Y; Liu M; Yu L; Gu C; Ma H Cardiovasc Diabetol; 2021 Jan; 20(1):30. PubMed ID: 33516224 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular Safety Trials for All New Diabetes Mellitus Drugs? Low Wang CC; Everett BM; Burman KD; Wilson PWF Circulation; 2019 Apr; 139(14):1741-1743. PubMed ID: 30933621 [No Abstract] [Full Text] [Related]
14. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study. Ou HT; Chang KC; Li CY; Wu JS Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742 [TBL] [Abstract][Full Text] [Related]
15. Is glycemic control a quinidine-like intervention? Bloomgarden ZT J Diabetes; 2014 Sep; 6(5):387-8. PubMed ID: 24842383 [No Abstract] [Full Text] [Related]
16. Metformin: the past, presence, and future. Alušík Š; Paluch Z Minerva Med; 2015 Aug; 106(4):233-8. PubMed ID: 25532538 [TBL] [Abstract][Full Text] [Related]
17. Diabetes: Time for reconciliation between cardiologists and diabetologists. Scheen AJ Nat Rev Cardiol; 2016 Sep; 13(9):509-10. PubMed ID: 27411401 [No Abstract] [Full Text] [Related]
18. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes]. André P Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683 [No Abstract] [Full Text] [Related]
19. Glucose lowering strategies and cardiovascular disease in type 2 diabetes - teachings from the TOSCA.IT study. Vaccaro O; Masulli M; Riccardi G Nutr Metab Cardiovasc Dis; 2018 Jul; 28(7):722-726. PubMed ID: 29804832 [TBL] [Abstract][Full Text] [Related]